C. elegans in high-throughput drug discovery

Caenorhabditis elegans has been proven to be a useful model organism for investigating molecular and cellular aspects of numerous human diseases. More recently, investigators have explored the use of this organism as a tool for drug discovery. Although earlier drug screens were labor-intensive and low in throughput, recent advances in high-throughput liquid workflows, imaging platforms and data analysis software have made C elegans a viable option for automated high-throughput drug screens. This review will outline the evolution of C elegans-based drug screening, discuss the inherent challenges of using C elegans, and highlight recent technological advances that have paved the way for future drug screens. (C) 2013 Elsevier B.V. All rights reserved.